VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PRQRProQR Therapeutics N.V.
$1.64$172M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRQRQuarterly Cash Flow

ProQR Therapeutics N.V. (PRQR) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ProQR Therapeutics N.V. (PRQR) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

PRQR Cash Flow Statement

Quarterly statement

PRQR Cash Flow Statement

ProQR Therapeutics N.V. (PRQR) cash flow statement — 13-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-12.4M-11.14M-13.36M-12.23M-11.4M-15.8M-9.35M-5.66M-6.26M-15.13M-5.32M-7.51M-10.35M44.73M-17.83M-15.36M-14.84M-20.47M3.79M-8.06M
Operating CF Margin %-139.29%-539.34%-284.92%-419.73%-298.69%-349.59%-217.04%-147.2%-99.22%-340.04%-162.06%-548.03%-832.42%6416.79%-1472.58%-1730.18%-1442.57%-1662.63%852.48%-695.77%
Operating CF Growth %-8.79%29.45%-42.89%-116.28%-82.24%-4.4%-75.65%24.65%39.54%-133.83%70.16%51.13%30.3%318.52%-571.15%-90.69%-48.75%-74.02%132.2%17.87%
Net Income-8.87M-13.38M-8.92M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.42M-7.98M-8.86M-11.39M-23.3M-13.48M-14.12M-18.24M-15.07M
Depreciation & Amortization718.71K694K679K671K675K678K671K688K711K691K728K642K594K549K748K612K591K570K552K544K
Stock-Based Compensation01.43M1.23M1.12M909K758K568K612K628K736K802K444K765K1.09M-387K1.33M738K1.18M1.78M1.72M
Deferred Taxes001K018K000-200K3K5K-83K00-96K69K20K7K22K35K
Other Non-Cash Items1.6M7K96K57K354K-434K-739K34K-89K320K-3.67M-1.08M-107K-354K-1.04M2.32M-3.63M-4.16M-128K-119K
Working Capital Changes-5.85M109K-6.44M-3.07M-1.18M-6.72M-543K1.12M-4.61M-9.22M2.3M-2.01M-3.62M52.29M-5.67M3.61M916K-3.95M19.8M4.84M
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables00000000000000000000
Cash from Investing-294.78K-164K-526K-169K-101K-224K-2.79M16.71M-267K-17.73M5M-339K-294K-89K19K-246K-231K-244K-166K-175K
Capital Expenditures-294.78K-164K-526K-169K-101K-224K-133K-286K-267K-732K-602K-339K-294K-136K13K-246K-231K-244K-225K-175K
CapEx % of Revenue3.31%7.94%11.22%5.8%2.65%4.96%3.09%7.44%4.23%16.45%18.33%24.74%23.65%19.51%1.07%27.7%22.45%19.82%50.68%15.11%
Acquisitions000000000000005.72K00000
Investments--------------------
Other Investing000000-2.65M0005.6M0047K28100059K0
Cash from Financing49.39M-304K-599K-444K-293K-500K71.43M-453K-282K-419K-1.09M-281K-643K-259K13.76M-43.75M-357K-543K26.94M23.56M
Debt Issued (Net)-621K-304K-601K-444K-293K-567K-253K-454K-294K-581K-1.29M-432K-647K-259K-359K-43.75M-357K-576K26.58M-63K
Equity Issued (Net)50.02M02K0000000000014.12M000023.22M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-8.36K000067K71.68M1K12K162K199K151K4K01K0033K363K402K
Net Change in Cash35.39M-11.32M-14.47M-12.88M-12.65M-16.99M60.01M10.43M-6.74M-33.21M-1.63M-8.01M-10.42M44.21M-5.66M-55.97M-11.21M-19.91M31.38M16.7M
Free Cash Flow-12.7M-11.31M-13.88M-12.4M-11.5M-16.02M-9.48M-5.94M-6.52M-15.86M-5.92M-7.85M-10.64M44.59M-17.82M-15.61M-15.07M-20.71M3.56M-8.23M
FCF Margin %-142.61%-547.27%-296.14%-425.52%-301.34%-354.55%-220.13%-154.64%-103.46%-356.49%-180.39%-572.77%-856.07%6397.27%-1471.51%-1757.88%-1465.02%-1682.45%801.8%-710.88%
FCF Growth %-10.39%29.42%-46.43%-108.72%-76.33%-1%-60.04%24.26%38.7%-135.58%66.76%49.73%29.41%315.29%-600.56%-89.63%-50.28%-75.62%129.98%18.28%
FCF per Share-0.12-0.11-0.13-0.11-0.11-0.15-0.12-0.07-0.08-0.19-0.08-0.10-0.130.55-0.23-0.22-0.21-0.290.05-0.12
FCF Conversion (FCF/Net Income)1.40x0.82x1.50x1.11x0.94x1.57x1.00x0.70x2.32x1.98x0.97x1.31x1.29x-5.01x1.34x0.66x1.08x1.45x-0.21x0.54x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000